Trial intelligence / Profile preview

Postpartum breast milk transfer study of gabapentin and pregabalin

ACTRN12614000447651Phase 4Not yet recruiting

Sponsor
King Edward Memorial Hospital
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in pain comparing Gabapentin with Pregabalin (2 arms). Primary endpoint: Quantitative analysis of gabapentin and pregabalin levels in breast milk and maternal plasma for pharmacokinetic modelling. Planned start Jan 2016; status: not yet recruiting.

02

Drugs

gabapentinpregabalin
03

Conditions

pain

Beyond the preview

Go deeper on ACTRN12614000447651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614000447651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call